BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Roivant Expands Senior Leadership with Key Hires

  Dr. Sam Azoulay as Chief Medical Officer and Adele Gulfo as Chief of Commercial Development

  May 16, 2018

   · 

  3 min read
• Genetown

  EIP Pharma Secures $20.5 Million in Series B Financing

  Proceeds to Support Continued Development of Neflamapimod for Alzheimer’s Disease

  May 16, 2018

   · 

  3 min read
• Business

  GeneNews Announces Q1 2018 Results and Provides Progress Update

  Number of enrolled and active practices continues to grow

  May 16, 2018

   · 

  4 min read
• Business

  Sensei Biotherapeutics Appoints John Celebi as President and Chief Executive Officer

  Experienced Biotechnology Executive to Lead Company’s Growth Strategy for Cancer Immunotherapies, Including Lead Clinical Candidate SNS-301

  May 16, 2018

   · 

  4 min read
• Business

  Zoetis to Acquire Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments

  Purchase price of US $83 per share in cash, or approximately $2.0 billion in aggregate

  May 16, 2018

   · 

  11 min read
• Business

  Glassbeam Signs RES as a Strategic Reseller and Scripps Health as Customer Deployment

  Agreement Combines Glassbeam Analytics with Reseller RES’s Domain Expertise at Scripps

  May 16, 2018

   · 

  3 min read
• Business

  Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System

  Company’s rental program limits upfront expenditures for hospitals and provides them with greater financial flexibility and maximum ROI

  May 16, 2018

   · 

  6 min read
• Genetown

  KalVista Pharmaceuticals Recognizes HAE Day

  A Global Awareness Day for a Rare Life-Threatening Condition

  May 16, 2018

   · 

  4 min read
• FDA

  Bioverativ and Sangamo Announce FDA Acceptance of IND Application for Gene-Edited Cell Therapy BIVV003 to Treat Sickle Cell Disease

  BIVV003 is a gene-edited cell therapy candidate for the treatment of people with sickle cell disease

  May 16, 2018

   · 

  6 min read
• Business

  Quentis Therapeutics Announces the Appointment of Jeanne Magram, Ph.D. as Chief Scientific Officer

  Quentis is a biotechnology company pursuing first-in-class endoplasmic reticulum stress response-targeted therapies to address serious diseases such as cancer

  May 16, 2018

   · 

  4 min read